Jpmorgan Chase & CO Abeona Therapeutics Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 282,259 shares of ABEO stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
282,259
Previous 282,259 -0.0%
Holding current value
$1.26 Million
Previous $1.49 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$5.28 - $7.23 $256,080 - $350,655
48,500 Added 20.75%
282,259 $1.49 Million
Q1 2025

May 12, 2025
BUY
$4.76 - $6.02 $1.11 Million - $1.41 Million
233,745 Added 1669607.12%
233,759 $1.11 Million
Q4 2024

Feb 12, 2025
SELL
$5.55 - $6.67 $372,538 - $447,717
-67,124 Reduced 99.98%
14 $0
Q3 2024

Dec 26, 2024
BUY
$4.12 - $6.32 $117,856 - $180,789
28,606 Added 74.24%
67,138 $424,000
Q3 2024

Nov 08, 2024
BUY
$4.12 - $6.32 $117,856 - $180,789
28,606 Added 74.24%
67,138 $424,000
Q2 2024

Dec 26, 2024
SELL
$3.17 - $8.05 $90,681 - $230,278
-28,606 Reduced 42.61%
38,532 $163,000
Q2 2024

Aug 12, 2024
BUY
$3.17 - $8.05 $53,471 - $135,787
16,868 Added 77.86%
38,532 $163,000
Q1 2024

Dec 26, 2024
SELL
$4.07 - $8.68 $185,079 - $394,714
-45,474 Reduced 67.73%
21,664 $157,000
Q1 2024

May 10, 2024
BUY
$4.07 - $8.68 $88,115 - $187,922
21,650 Added 154642.86%
21,664 $157,000
Q4 2023

Dec 26, 2024
SELL
$3.71 - $5.14 $249,030 - $345,017
-67,124 Reduced 99.98%
14 $0
Q2 2023

Aug 11, 2023
SELL
$2.76 - $5.27 $1,943 - $3,710
-704 Reduced 98.05%
14 $0
Q1 2023

May 11, 2023
BUY
$2.25 - $3.27 $1,584 - $2,302
704 Added 5028.57%
718 $2,000
Q4 2022

Feb 13, 2023
SELL
$2.4 - $5.65 $2 - $5
-1 Reduced 6.67%
14 $0
Q3 2022

Nov 14, 2022
BUY
$2.79 - $5.56 $41 - $83
15 New
15 $0

Others Institutions Holding ABEO

# of Institutions
109
Shares Held
32.9M
Call Options Held
1.34M
Put Options Held
271K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $26.5M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email